
FDA upgrades nationwide honey brand recall over steel shards discovered
The FDA issued a recall for hundreds of jars of three Queen Bee Gardens whipped honey products on July 16.
Experts warn that consuming small flakes of stainless steel can pose a choking hazard if they are 7mm (0.3 inches) or larger, especially for young children.
But on August 1, the department updated the recall to Class II, meaning that the use of any these products can cause temporary or medically reversible adverse health consequences.
The recalled products, which were distributed throughout the US, had been purchased between June 1 and July 16, 2025.
The Wyoming-based company had manufactured the Whipped Honey Raspberry and QBee Whipped Honey Pure products, both with lot codes 206235, on June 23.
The QBee Whipped Honey Huckleberry with the lot code 206305 was made on June 30.
While it remains unclear how the flakes entered the whipped honey jars, experts believe it could be due to degradation of older or non-food-grade metal equipment, improper handling or cleaning of equipment.
The recalled products include 129 jars of QBee Whipped Honey Raspberry with the UPC 788394182358, 112 jars of QBee Whipped Honey Pure with the UPC 788394182006, and 24 jars of QBee Whipped Honey Huckleberry with the UPC 788394182259.
In most cases, accidentally ingesting a small flake of stainless steel is unlikely to cause serious harm and can easily pass through the digestive system.
However, stainless steel contains nickel, a common allergen which can be released from the metal into food items.
When consumed in excessive amounts through food items such as whipped honey, these stainless steel flakes can cause allergic reactions such as contact dermatitis, presenting as itchy rashes and redness.
In severe cases, the skin may become dry, scaly or develop blisters.
Additionally, if the flakes have sharp edges, they could potentially scratch the throat or cause internal injuries in the digestive system.
Consuming steel flakes can be especially dangerous for infants, young children and others in special risk groups as it may cause difficulty breathing, coughing, gagging and trouble breathing.
Ingestion of metal fragments can also lead to a range of symptoms, including abdominal pain, vomiting, bloody stool, chest or throat pain in young children.
Consumers who experience any health concerns related to the ingestion of these or similar products are encouraged to consult a medical professional and report the incident to the FDA's MedWatch program.
No incidents of injury caused by consuming the contaminated whipped honey have yet been reported.
This comes weeks after a recall was issued for ready-to-eat chicken sausages over fears of throat lacerations, health officials announced.
Massachusetts-based Kayem Foods Inc has voluntarily recalled 24,000lbs of its 'All Natural Al Fresco Chicken Sausage Sweet Apple with Vermont Maple Syrup' after customers reported finding white pieces of plastic inside of them.
The US Department of Agriculture (USDA) said it was 'concerned that some products may be in consumers' refrigerators or freezers.'
'The problem was discovered after the firm notified USDA-Food Safety Inspection Service that it received three consumer complaints reporting white pieces of plastic in the chicken sausage products,' the agency said.
Affected products were produced on June 28, 2025, and have a use- or freeze-by date of October 1, 2025.
Each 11-ounce package contains four sausages and has the lot code 179 printed on the back package label. They also have 'P-7839' printed on the inside of the USDA mark of inspection.
The sausages were sold at Walmart and other retailers in 26 states, Washington DC and Puerto Rico.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
43 minutes ago
- Reuters
Dialysis firm FMC's earnings miss market view, hit by severe flu season in US
Aug 5 (Reuters) - Dialysis specialist Fresenius Medical Care ( opens new tab missed analysts' earnings forecasts on Tuesday, after a severe flu season in the U.S. led to higher mortality among patients and a greater number of missed treatments in the first months of 2025. FMC, which makes the bulk of its sales in the U.S. and employs most of its staff there, however was "encouraged by the strong and accelerating momentum in patient referrals" that had continued in the second quarter, CEO Helen Giza said in a statement. But the positive development in patient inflow was offset by a higher than expected outflow due to higher mortality rates in the U.S. following the severe flu season, she added. That has impacted treatment numbers for the second quarter and for the remainder of the year, FMC said. The world's largest dialysis provider said its adjusted operating income grew 9% to 476 million euros ($550.2 million) in the second quarter, but missed analysts' average estimate of 492 million euros in a company-provided consensus. Its shares were down around 3% in early Frankfurt trade. U.S. same market treatment growth was flat year-on-year, as a rise in newly started treatments partially offset patient outflow. FMC has guided for same market treatment growth of more than 0.5% in the U.S. in 2025. Quarterly revenue grew 5% in constant currency terms to 4.79 billion euros, slightly above analysts' expectations, helped by savings of 58 million euros attributable to the group's FME25 transformation program. The German group confirmed its full-year guidance, as it expects "to realize further significant operational and financial improvements" in the second half of the year, Giza said. It also said it would initiate the first tranche of its 1 billion euro share buyback programme in August. ($1 = 0.8651 euros)


Reuters
4 hours ago
- Reuters
Sandoz to offer generic weight-loss drugs in Canada at up to 70% discount, FT reports
Aug 5 (Reuters) - Swiss generic drug manufacturer Sandoz (SDZ.S), opens new tab plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard Saynor told the Financial Times. Sandoz is yet to finalise the pricing for its generic weight-loss and diabetes drug semaglutide, but a price cut of "60 or 70 per cent of the list price" was achievable, Saynor told the newspaper. Prices could drop further as more generic versions become available, Saynor said, noting, "If you were selling this at $40 or $50 a month, the market could be two or three times bigger in terms of the number of patients." Branded weight-loss and diabetes medications, such as Novo Nordisk's Ozempic and Wegovy, and Eli Lilly's Mounjaro and Zepbound, are currently priced between $200 and $400 for a one-month supply, according to the FT report. Novo Nordisk's medications use semaglutide as the active ingredient, while Eli Lilly's medications use tirzepatide. Sandoz did not immediately respond to a Reuters request for comment. The move comes as demand for weight-loss and diabetes drugs has surged globally, driven by their effectiveness in managing obesity and diabetes. Last month, a top Biocon executive told Reuters that the biopharmaceutical company aims to launch generic copies of the blockbuster weight-loss drug Wegovy in Canada within the next two years.


Daily Mail
4 hours ago
- Daily Mail
The beauty powder that has TikTok obsessed - with users noticing results in DAYS: 'People actually asked what I've been using'
Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more If you have ever found yourself scrolling endlessly on TikTok, it is more than likely that you have seen the viral wellness brand Bloom Nutrition. Influencers, celebrities, and social media users alike have been seen blending up the brand's famous Greens & Superfoods Powder time and time again, with the amount of rave reviews seemingly endless. The popular brand is wowing users yet again with their Colostrum & Collagen Peptides powder that has been coined a 3-in-1 beauty supplement. The unique combination of colostrum, collagen, and supporting ingredients such as vitamins comes together to create a one-of-a-kind wellness experience. And the best part is it is only $30 on Amazon! Now let's get into the nitty-gritty. The uniqueness of the Colostrum & Collagen Peptides powder comes down to what it's made with. The daily powder, which can be mixed into any liquid, uses grass-fed Collagen, a probiotic blend, and bioactive colostrum. Together, these three major components are creating a versatile wellness supplement that aims to support a plethora of beauty concerns, including tighter skin, thicker hair, scalp health, and more. Plus, it remains a gut-positive powder similar to Bloom Nutrition's other viral products! Non-GMO, third-party tested, and sustainably sourced — the list of green flags when it comes to the secrets behind the Colostrum & Collagen Peptides powder is vast. Users agree, with one saying: 'The health benefits I saw after only taking this for 3 days were insane! Easy to mix with any drink, even water! Doesn't have any weird smell to throw it off, it's so effective!! Felt like it made my gut health improve tremendously.' The increasingly popular 3-in-1 beauty supplement currently comes in a non-flavored version and two other delicious options, Strawberries & Cream and Orange & Cream. The dessert-themed flavors have been a hit this summer with shoppers calling them 'nostalgic.' Never before has there been such a sweet wellness cheat code! One user of the Orange & Cream powder said: 'I originally purchased this from the store because colostrum seems to be all the rage, and I love the nostalgic flavor of orange cream. I'm looking to improve my skin, hair, and nails since I'm aging. 'I really like this... I'm noticing improvement over the last couple of months, and quite a few people actually asked what I've been using, so I'm sold!' Whether you are looking to support hair growth, get brighter skin, or aide your gut — Bloom nutrition's Colostrum & Collagen Peptides powder has your back.